Valuation

ALCAlcon

StockNYSESwitzerlandHealth careEU retail investors: available

−1.4% today · 0.0% over a year

4/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 42% of the instruments we score

Priced lower than most peers. Dividend yield 0.40%.

Alcon (ALC) valuation against sector peers: P/E 36.8 (sector median 25.7), P/B 1.6, EV/EBIT 28.8, free-cash-flow yield 4.8%, P/S 3.5.

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
MetricALCSector medianvs median
P/E36.825.7 · n=2643% above
P/B1.63.6 · n=4555% below
P/S3.54.7 · n=4026% below
EV/EBIT28.822.6 · n=2827% above
Free-cash-flow yield4.8%3.8% · n=3928% above
Dividend yield0.40%0.19% · n=99105% above
Return on equity4.5%5.2% · n=5614% below
Return on invested capital4.6%6.5% · n=4729% below
Gross margin55.2%70.2% · n=3921% below
Net debt / EBITDA—2.08 · n=25—

Value factor: 65 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

NOVNNovartis AG22.46.818.75.6%2.8%10/10
NVSNovartis AG22.36.818.75.6%2.4%10/10
AZNAstraZeneca PLC28.35.922.84.1%1.2%5/10
AZNAstraZeneca plc28.35.922.84.1%1.7%6/10
NVONovo Nordisk A/S11.86.210.34.9%4.6%7/10
SNYSanofi13.41.518.26.9%4.3%7/10
SANSanofi SA13.41.518.26.9%4.8%9/10
GSKGSK plc14.55.111.87.7%3.5%9/10
TEVATeva Pharmaceutical Industries Limited97.86.243.32.5%0.0%6/10
ALCAlcon AG37.51.729.34.7%0.5%5/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 31 Dec 2025 · filed 24 Feb 2026